US FDA expands use of Avadel's sleep disorder drug to ages 7 and up
The U.S. Food and Drug Administration has approved Avadel Pharmaceuticals' sleep disorder drug for children aged 7 years and ...
US FDA expands approval for Avadel's sleep disorder drug
The U.S. Food and Drug Administration has approved Avadel Pharmaceuticals' sleep disorder drug for children aged 7 years and ...
Americans are losing faith in food safety. Is the system to blame?
Public confidence in the U.S. government’s ability to protect the food supply is at an all-time low, according to a recent ...
Arthritis and Joint Pain Supplements Recalled Due to Undeclared Drugs
Tablets labeled as dietary supplements for joint pain and arthritis are being recalled after the FDA found three undeclared ...
Weight loss drugs may help reduce drug and alcohol abuse: Research
Weight loss medications such as Ozempic may be able to cut drug and alcohol abuse in half, according to a new study from the ...
ConsumerAffairs19 小时
Compounding pharmacies can keep making Mounjaro and Zepbound copies
The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...
3 states renew their effort to reduce access to the abortion drug mifepristone
Three states are asking a judge to let them try a new approach with a lawsuit to force the federal government to reduce ...
Column: Listeria hysteria or just another food recall?
Nearly 11 million pounds of ready-to-eat meat and chicken, produced by the Oklahoma-based BrucePac, have been recalled ...
Food and Drug Administration Celebrates the 6th Cosmetics Day
The Ministry of Food and Drug Safety held the 6th Cosmetics Day celebration with the Korea Cosmetics Association today (17th).Under the slogan "K-Cosmetics, ...
CacheValleyDaily.com10 小时
Gov. Spencer Cox announces new task force to address synthetic drug fentanyl
SALT LAKE CITY – Utah has declared war on the synthetic drug fentanyl. That news came on Oct. 15, when Gov. Spencer Cox ...
BioPharma Dive3 小时
After rejections, AbbVie secures approval for Parkinson’s drug
Vyalev’s clearance is the second victory for AbbVie in Parkinson’s this year, following an April readout for a drug acquired through its Cerevel buyout.